The drug’s manufacturer, Marksans Pharma Limited, has expanded a recall initially announced in June to now include an additional 76 unexpired lots of the medication.
The recalled drugs are marketed as “extended-release tablets” under the brand name Time-Cap Labs, Inc.
The recalled product contained an unacceptably high level of N-Nitrosodimethylamine, which is considered a probable human carcinogen.
https://nypost.com/2020/10/09/diabetes-drug-metformin-recalled-due-to-high-level-of-cancer-agent/